FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1478-1483 May 18, 2000 Number 20 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Cardiovascular disease is common in older adults with end-stage renal disease who are undergoing regular dialysis, but little is known about the prevalence and extent of cardiovascular disease in children and young adults with end-stage renal disease.

Methods We used electron-beam computed tomography (CT) to screen for coronary-artery calcification in 39 young patients with end-stage renal disease who were undergoing dialysis (mean [±SD] age, 19±7 years; range, 7 to 30) and 60 normal subjects 20 to 30 years of age. In those with evidence of calcification on CT scanning, we determined its extent. The results were correlated with the patients' clinical characteristics, serum calcium and phosphorus concentrations, and other biochemical variables.

Results None of the 23 patients who were younger than 20 years of age had evidence of coronary-artery calcification, but it was present in 14 of the 16 patients who were 20 to 30 years old. Among those with calcification, the mean calcification score was 1157± 1996, and the median score was 297. By contrast, only 3 of the 60 normal subjects had calcification. As compared with the patients without coronary-artery calcification, those with calcification were older (26±3 vs. 15±5 years, P<0.001) and had been undergoing dialysis for a longer period (14±5 vs. 4±4 years, P< 0.001). The mean serum phosphorus concentration, the mean calcium–phosphorus ion product in serum, and the daily intake of calcium were higher among the patients with coronary-artery calcification. Among 10 patients with calcification who underwent follow-up CT scanning, the calcification score nearly doubled (from 125±104 to 249±216, P=0.02) over a mean period of 20±3 months.

Conclusions Coronary-artery calcification is common and progressive in young adults with end-stage renal disease who are undergoing dialysis.

Source Information

From the Departments of Medicine (W.G.G., D.S.), Radiological Sciences (J.G., C.Y., A.E., L.G.), Pediatrics (B.D.K., B.G., I.B.S.), and Biomathematics (Y.W., J.C., R.M.E.), UCLA School of Medicine, Los Angeles.

Address reprint requests to Dr. Goodman at the Division of Nephrology, 7-155 Factor Bldg., UCLA Medical Center, 10833 Le Conte Ave., Los Angeles, CA 90095, or at wgoodman{at}ucla.edu.

Full Text of this Article

This article has been cited by other articles:

• Barraclough, K. A., Stevens, L. A., Er, L., Rosenbaum, D., Brown, J., Tiwari, P., Levin, A. (2008). Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure. Nephrol Dial Transplant 23: 3199-3205 [Abstract] [Full Text]  
• Shroff, R. C., Shah, V., Hiorns, M. P., Schoppet, M., Hofbauer, L. C., Hawa, G., Schurgers, L. J., Singhal, A., Merryweather, I., Brogan, P., Shanahan, C., Deanfield, J., Rees, L. (2008). The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23: 3263-3271 [Abstract] [Full Text]  
• Arcidiacono, M. V., Cozzolino, M., Spiegel, N., Tokumoto, M., Yang, J., Lu, Y., Sato, T., Lomonte, C., Basile, C., Slatopolsky, E., Dusso, A. S. (2008). Activator Protein 2{alpha} Mediates Parathyroid TGF-{alpha} Self-Induction in Secondary Hyperparathyroidism. J. Am. Soc. Nephrol. 19: 1919-1928 [Abstract] [Full Text]  
• Cseprekal, O., Kis, E., Schaffer, P., Othmane, T. E. H., Fekete, B. Cs., Vannay, A., Szabo, A. J., Remport, A., Szabo, A., Tulassay, T., Reusz, G. S. (2008). Pulse wave velocity in children following renal transplantation. Nephrol Dial Transplant 0: gfn494v1-gfn494 [Abstract] [Full Text]  
• Porazko, T., Kuzniar, J., Kusztal, M., Kuzniar, T. J., Weyde, W., Kuriata-Kordek, M., Klinger, M. (2008). IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant 0: gfn486v1-gfn486 [Abstract] [Full Text]  
• Kobayashi, S., Oka, M., Maesato, K., Ikee, R., Mano, T., Hidekazu, M., Ohtake, T. (2008). Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients. CJASN 3: 1289-1295 [Abstract] [Full Text]  
• Hsu, J. J., Tintut, Y., Demer, L. L. (2008). Vitamin D and Osteogenic Differentiation in the Artery Wall. CJASN 3: 1542-1547 [Abstract] [Full Text]  
• Mehrotra, R., Martin, K. J., Fishbane, S., Sprague, S. M., Zeig, S., Anger, M., for the Fosrenol Overview Research Evaluation Stud, (2008). Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and Physicians: A Multicenter Study. CJASN 3: 1437-1445 [Abstract] [Full Text]  
• Rohrscheib, M. R., Myers, O. B., Servilla, K. S., Adams, C. D., Miskulin, D., Bedrick, E. J., Hunt, W. C., Lindsey, D. E., Gabaldon, D., Zager, P. G., for the DCI Medical Directors, (2008). Age-related Blood Pressure Patterns and Blood Pressure Variability among Hemodialysis Patients. CJASN 3: 1407-1414 [Abstract] [Full Text]  
• London, G. M., Marchais, S. J., Guerin, A. P., Boutouyrie, P., Metivier, F., de Vernejoul, M.-C. (2008). Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD. J. Am. Soc. Nephrol. 19: 1827-1835 [Abstract] [Full Text]  
• Rodriguez-Garcia, M., Gomez-Alonso, C., Naves-Diaz, M., Diaz-Lopez, J. B., Diaz-Corte, C., Cannata-Andia, J. B., the Asturias Study Group, (2008). Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 0: gfn466v1-gfn466 [Abstract] [Full Text]  
• Honkanen, E., Kauppila, L., Wikstrom, B., Rensma, P. L., Krzesinski, J.-M., Aasarod, K., Verbeke, F., Jensen, P. B., Mattelaer, P., Volck, B., on behalf of the CORD study group, (2008). Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 0: gfn403v1-gfn403 [Abstract] [Full Text]  
• Schlieper, G., Hristov, M., Brandenburg, V., Kruger, T., Westenfeld, R., Mahnken, A. H., Yagmur, E., Boecker, G., Heussen, N., Gladziwa, U., Ketteler, M., Weber, C., Floege, J. (2008). Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 23: 2611-2618 [Abstract] [Full Text]  
• Nakamura, M., Marui, Y., Ubara, Y., Nakanishi, S., Takemoto, F., Takaichi, K., Tomikawa, S. (2008). Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy. NDT Plus 1: iii39-iii41 [Abstract] [Full Text]  
• Noonan, W., Koch, K., Nakane, M., Ma, J., Dixon, D., Bolin, A., Reinhart, G. (2008). Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats. Nephrol Dial Transplant 0: gfn375v1-gfn375 [Abstract] [Full Text]  
• Hunley, T. E., Kon, V., Jabs, K. (2008). Myocardial Infarction in Chronic Kidney Disease. Pediatrics 122: 223-224 [Full Text]  
• How, P. P., Mason, D. L., Lau, A. H. (2008). Current Approaches in the Treatment of Chronic Kidney Disease Mineral and Bone Disorder. Journal of Pharmacy Practice 21: 196-213 [Abstract]  
• Raggi, P., Kleerekoper, M. (2008). Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease. CJASN 3: 836-843 [Abstract] [Full Text]  
• Yamada, K., Fujimoto, S. (2008). Reply. Nephrol Dial Transplant 23: 1457-1458 [Full Text]  
• Ix, J. H., Katz, R., Kestenbaum, B., Fried, L. F., Kramer, H., Stehman-Breen, C., Shlipak, M. G. (2008). Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification. J. Am. Soc. Nephrol. 19: 579-585 [Abstract] [Full Text]  
• Bolland, M. J, Barber, P A., Doughty, R. N, Mason, B., Horne, A., Ames, R., Gamble, G. D, Grey, A., Reid, I. R (2008). Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336: 262-266 [Abstract] [Full Text]  
• Winzenberg, T., Jones, G. (2008). Recommended Calcium Intakes in Children: Have We Set the Bar Too High?. IBMS BoneKEy 5: 59-68 [Abstract] [Full Text]  
• Toussaint, N. D., Lau, K. K., Strauss, B. J., Polkinghorne, K. R., Kerr, P. G. (2008). Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23: 586-593 [Abstract] [Full Text]  
• Arcidiacono, M. V., Sato, T., Alvarez-Hernandez, D., Yang, J., Tokumoto, M., Gonzalez-Suarez, I., Lu, Y., Tominaga, Y., Cannata-Andia, J., Slatopolsky, E., Dusso, A. S. (2008). EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease. J. Am. Soc. Nephrol. 19: 310-320 [Abstract] [Full Text]  
• Phan, O., Ivanovski, O., Nikolov, I. G., Joki, N., Maizel, J., Louvet, L., Chasseraud, M., Nguyen-Khoa, T., Lacour, B., Drueke, T. B., Massy, Z. A. (2008). Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure. Nephrol Dial Transplant 23: 82-90 [Abstract] [Full Text]  
• Eller, P., Hochegger, K., Feuchtner, G. M., Zitt, E., Tancevski, I., Ritsch, A., Kronenberg, F., Rosenkranz, A. R., Patsch, J. R., Mayer, G. (2008). Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant 23: 321-327 [Abstract] [Full Text]  
• Tomasello, S. (2008). Secondary Hyperparathyroidism and Chronic Kidney Disease. Diabetes Spectr. 21: 19-25 [Abstract] [Full Text]  
• Caglar, K., Yilmaz, M. I., Saglam, M., Cakir, E., Acikel, C., Eyileten, T., Yenicesu, M., Oguz, Y., Vural, A., Carrero, J. J., Axelsson, J., Lindholm, B., Stenvinkel, P. (2008). Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients. CJASN 3: 61-68 [Abstract] [Full Text]  
• Kovesdy, C. P., Mehrotra, R., Kalantar-Zadeh, K. (2008). Battleground: Chronic Kidney Disorders Mineral and Bone Disease Calcium Obsession, Vitamin D, and Binder Confusion. CJASN 3: 168-173 [Abstract] [Full Text]  
• Andress, D. L. (2008). Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision. CJASN 3: 179-183 [Abstract] [Full Text]  
• Cannata-Andia, J. B., Carrera, F. (2008). The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. NDT Plus 1: i2-i6 [Abstract] [Full Text]  
• Bushinsky, D. A., Messa, P. (2008). Efficacy of Early Treatment with Calcimimetics in Combination with Reduced Doses of Vitamin D Sterols in Dialysis Patients. NDT Plus 1: i18-i23 [Abstract] [Full Text]  
• de Francisco, A. L. M., Carrera, F. (2008). A New Paradigm for the Treatment of Secondary Hyperparathyroidism. NDT Plus 1: i24-i28 [Abstract] [Full Text]  
• Cunningham, J., Floege, J., London, G., Rodriguez, M., Shanahan, C. M. (2008). Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics. NDT Plus 1: i29-i35 [Abstract] [Full Text]  
• Chonchol, M., Wuthrich, R. P. (2008). Potential Future Uses of Calcimimetics in Patients with Chronic Kidney Disease. NDT Plus 1: i36-i41 [Abstract] [Full Text]  
• Ravani, P., Parfrey, P. S., Curtis, B., Barrett, B. J. (2007). Clinical research of kidney diseases 1: researchable questions and valid answers. Nephrol Dial Transplant 22: 3681-3690 [Full Text]  
• Bos, M. J., Koudstaal, P. J., Hofman, A., Breteler, M. M.B. (2007). Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study. Stroke 38: 3127-3132 [Abstract] [Full Text]  
• Porter, C. J., Stavroulopoulos, A., Roe, S. D., Pointon, K., Cassidy, M. J.D. (2007). Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant 22: 3208-3213 [Abstract] [Full Text]  
• Shroff, R. C., Donald, A. E., Hiorns, M. P., Watson, A., Feather, S., Milford, D., Ellins, E. A., Storry, C., Ridout, D., Deanfield, J., Rees, L. (2007). Mineral Metabolism and Vascular Damage in Children on Dialysis. J. Am. Soc. Nephrol. 18: 2996-3003 [Abstract] [Full Text]  
• Palmer, S. C., Craig, J. C., Strippoli, G. F. M. (2007). Sevelamer: a promising but unproven drug. Nephrol Dial Transplant 22: 2742-2745 [Full Text]  
• Voormolen, N., Noordzij, M., Grootendorst, D. C., Beetz, I., Sijpkens, Y. W., van Manen, J. G., Boeschoten, E. W., Huisman, R. M., Krediet, R. T., Dekker, F. W., the PREPARE study group, (2007). High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22: 2909-2916 [Abstract] [Full Text]  
• Nakashima, D., Takama, H., Ogasawara, Y., Kawakami, T., Nishitoba, T., Hoshi, S., Uchida, E., Tanaka, H. (2007). Effect of Cinacalcet Hydrochloride, a New Calcimimetic Agent, on the Pharmacokinetics of Dextromethorphan: In Vitro and Clinical Studies. J Clin Pharmacol 47: 1311-1319 [Abstract] [Full Text]  
• Ravani, P., Parfrey, P. S., Curtis, B., Barrett, B. J. (2007). Clinical research of kidney diseases 1: researchable questions and valid answers. Nephrol Dial Transplant 22: 2459-2468 [Full Text]  
• Kwan, B. C.H., Murtaugh, M. A., Beddhu, S. (2007). Associations of Body Size with Metabolic Syndrome and Mortality in Moderate Chronic Kidney Disease. CJASN 2: 992-998 [Abstract] [Full Text]  
• Chertow, G. M., Pupim, L. B., Block, G. A., Correa-Rotter, R., Drueke, T. B., Floege, J., Goodman, W. G., London, G. M., Mahaffey, K. W., Moe, S. M., Wheeler, D. C., Albizem, M., Olson, K., Klassen, P., Parfrey, P. (2007). Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview. CJASN 2: 898-905 [Abstract] [Full Text]  
• Rudser, K. D., de Boer, I. H., Dooley, A., Young, B., Kestenbaum, B. (2007). Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients. J. Am. Soc. Nephrol. 18: 2401-2407 [Abstract] [Full Text]  
• Nogueira, J., Weir, M. (2007). The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs. CJASN 2: 766-785 [Abstract] [Full Text]  
• Yajima, A., Inaba, M., Ogawa, Y., Tominaga, Y., Tanizawa, T., Inou, T., Otsubo, O. (2007). Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism. Nephrol Dial Transplant 22: 1645-1657 [Abstract] [Full Text]  
• Raggi, P., Bellasi, A., Ferramosca, E., Block, G. A., Muntner, P. (2007). Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients. Hypertension 49: 1278-1284 [Abstract] [Full Text]  
• Kronmal, R. A., McClelland, R. L., Detrano, R., Shea, S., Lima, J. A., Cushman, M., Bild, D. E., Burke, G. L. (2007). Risk Factors for the Progression of Coronary Artery Calcification in Asymptomatic Subjects: Results From the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 115: 2722-2730 [Abstract] [Full Text]  
• Dhingra, R., Sullivan, L. M., Fox, C. S., Wang, T. J., D'Agostino, R. B. Sr, Gaziano, J. M., Vasan, R. S. (2007). Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community. Arch Intern Med 167: 879-885 [Abstract] [Full Text]  
• John, R., Lietz, K., Huddleston, S., Matas, A., Liao, K., Shumway, S., Joyce, L., Bolman, R. M. (2007). Perioperative outcomes of cardiac surgery in kidney and kidney pancreas transplant recipients. J. Thorac. Cardiovasc. Surg. 133: 1212-1219 [Abstract] [Full Text]  
• Villa-Bellosta, R., Bogaert, Y. E., Levi, M., Sorribas, V. (2007). Characterization of Phosphate Transport in Rat Vascular Smooth Muscle Cells: Implications for Vascular Calcification. Arterioscler. Thromb. Vasc. Bio. 27: 1030-1036 [Abstract] [Full Text]  
• Sharma, R., Chemla, E., Tome, M., Mehta, R. L, Gregson, H., Brecker, S. J D, Chang, R., Pellerin, D. (2007). Echocardiography-based score to predict outcome after renal transplantation. Heart 93: 464-469 [Abstract] [Full Text]  
• Bazari, H., Jaff, M. R., Mannstadt, M., Yan, S. (2007). Case 7-2007 -- A 59-Year-Old Woman with Diabetic Renal Disease and Nonhealing Skin Ulcers. NEJM 356: 1049-1057 [Full Text]  
• Krasniak, A., Drozdz, M., Pasowicz, M., Chmiel, G., Michalek, M., Szumilak, D., Podolec, P., Klimeczek, P., Konieczynska, M., Wicher-Muniak, E., Tracz, W., Khoa, T. N., Souberbielle, J.-C., Drueke, T. B., Sulowicz, W. (2007). Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 22: 515-521 [Abstract] [Full Text]  
• Toussaint, N. D., Lau, K. K., Polkinghorne, K. R., Kerr, P. G. (2007). Measurement of vascular calcification using CT fistulograms. Nephrol Dial Transplant 22: 484-490 [Abstract] [Full Text]  
• London, G. M., Guerin, A. P., Verbeke, F. H., Pannier, B., Boutouyrie, P., Marchais, S. J., Metivier, F. (2007). Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency. J. Am. Soc. Nephrol. 18: 613-620 [Abstract] [Full Text]  
• Greenland, P., Bonow, R. O., Brundage, B. H., Budoff, M. J., Eisenberg, M. J., Grundy, S. M., Lauer, M. S., Post, W. S., Raggi, P., Redberg, R. F., Rodgers, G. P., Shaw, L. J., Taylor, A. J., Weintraub, W. S., Harrington, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Eisenberg, M. J., Grines, C. L., Hlatky, M. A., Lichtenberg, R. C., Lindner, J. R., Pohost, G. M., Schofield, R. S., Shubrooks, S. J. Jr, Stein, J. H., Tracy, C. M., Vogel, R. A., Wesley, D. J. (2007). ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain: A Report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49: 378-402 [Full Text]  
• Mathew, S., Lund, R. J., Strebeck, F., Tustison, K. S., Geurs, T., Hruska, K. A. (2007). Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy. J. Am. Soc. Nephrol. 18: 122-130 [Abstract] [Full Text]  
• Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., Steinberger, J. (2006). Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 114: 2710-2738 [Abstract] [Full Text]  
• Nikolov, I., Joki, N., Drueke, T., Massy, Z. (2006). Beyond phosphate--role of uraemic toxins in cardiovascular calcification. Nephrol Dial Transplant 21: 3354-3357 [Full Text]  
• Achinger, S. G., Ayus, J. C. (2006). Left Ventricular Hypertrophy: Is Hyperphosphatemia among Dialysis Patients a Risk Factor?. J. Am. Soc. Nephrol. 17: S255-S261 [Abstract] [Full Text]  
• Cannata-Andia, J. B., Rodriguez-Garcia, M., Carrillo-Lopez, N., Naves-Diaz, M., Diaz-Lopez, B. (2006). Vascular Calcifications: Pathogenesis, Management, and Impact on Clinical Outcomes. J. Am. Soc. Nephrol. 17: S267-S273 [Abstract] [Full Text]  
• de Francisco, A. L.M., Pinera, C., Palomar, R., Arias, M. (2006). Impact of Treatment with Calcimimetics on Hyperparathyroidism and Vascular Mineralization. J. Am. Soc. Nephrol. 17: S281-S285 [Abstract] [Full Text]  
• Edwards, N.C., Steeds, R.P., Ferro, C.J., Townend, J.N. (2006). The treatment of coronary artery disease in patients with chronic kidney disease. QJM 99: 723-736 [Abstract] [Full Text]  
• Nijenhuis, T., van der Eerden, B. C. J., Zugel, U., Steinmeyer, A., Weinans, H., Hoenderop, J. G. J., van Leeuwen, J. P. T. M., Bindels, R. J. M. (2006). The novel vitamin D analog ZK191784 as an intestine-specific vitamin D antagonist. FASEB J. 20: 2171-2173 [Abstract] [Full Text]  
• Tomiyama, C., Higa, A., Dalboni, M. A., Cendoroglo, M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Neto, E. M., Canziani, M. E. F. (2006). The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 21: 2464-2471 [Abstract] [Full Text]  
• Persy, V., Postnov, A., Neven, E., Dams, G., De Broe, M., D'Haese, P., De Clerck, N. (2006). High-Resolution X-Ray Microtomography Is a Sensitive Method to Detect Vascular Calcification in Living Rats With Chronic Renal Failure. Arterioscler. Thromb. Vasc. Bio. 26: 2110-2116 [Abstract] [Full Text]  
• Spasovski, G. B., Sikole, A., Gelev, S., Masin-Spasovska, J., Freemont, T., Webster, I., Gill, M., Jones, C., De Broe, M. E., D'Haese, P. C. (2006). Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant 21: 2217-2224 [Abstract] [Full Text]  
• Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., Whooley, M. A. (2006). Fetuin-A and kidney function in persons with coronary artery disease--data from the heart and soul study. Nephrol Dial Transplant 21: 2144-2151 [Abstract] [Full Text]  
• Savica, V., Calo, L. A., Monardo, P., Santoro, D., Bellinghieri, G. (2006). Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrol Dial Transplant 21: 2065-2068 [Full Text]  
• Briese, S., Wiesner, S., Will, J. C., Lembcke, A., Opgen-Rhein, B., Nissel, R., Wernecke, K.-D., Andreae, J., Haffner, D., Querfeld, U. (2006). Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease--impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21: 1906-1914 [Abstract] [Full Text]  
• Jung, H. H., Kim, S.-W., Han, H. (2006). Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21: 1915-1920 [Abstract] [Full Text]  
• Rivet, J., Lebbe, C., Urena, P., Cordoliani, F., Martinez, F., Baglin, A. C., Aubert, P., Aractingi, S., Ronco, P., Fournier, P., Janin, A. (2006). Cutaneous calcification in patients with end-stage renal disease: a regulated process associated with in situ osteopontin expression.. Arch Dermatol 142: 900-906 [Abstract] [Full Text]  
• Pennick, M., Dennis, K., Damment, S. J. P. (2006). Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate.. J Clin Pharmacol 46: 738-746 [Abstract] [Full Text]  
• Moe, S. M., Chertow, G. M. (2006). The Case against Calcium-Based Phosphate Binders. CJASN 1: 697-703 [Abstract] [Full Text]  
• Bushinsky, D. A. (2006). Phosphate Binders: Hold the Calcium?. CJASN 1: 695-696 [Full Text]  
• Ulrich, C., Heine, G. H., Garcia, P., Reichart, B., Georg, T., Krause, M., Kohler, H., Girndt, M. (2006). Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease. Nephrol Dial Transplant 21: 1596-1602 [Abstract] [Full Text]  
• Ketteler, M., Schlieper, G., Floege, J. (2006). Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon. Hypertension 47: 1027-1034 [Full Text]  
• Hemmelgarn, B. R., Southern, D. A., Humphries, K. H., Culleton, B. F., Knudtson, M. L., Ghali, W. A., for the Alberta Provincial Project for Outcomes As, (2006). Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J 27: 1191-1197 [Abstract] [Full Text]